Prevention of Venous Thromboembolisms: How to Identify and Manage Patients at Risk
On-Demand 1.0 hour Accredited Webcast
Part 1 of a 2-module CE Webinar Curriculum
This activity is supported by an educational grant from
Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC.
Faculty Presenter
Sean P. Kane, PharmD, BCPS
Associate Professor, Pharmacy Practice
Assistant Dean for Assessment
Rosalind Franklin University of Medicine and Science
North Chicago, Illinois
Critical Care Pharmacist
Advocate Condell Medical Center
Libertyville, Illinois
Program Description
Venous thromboembolism (VTE) events are linked with serious health complications for patients of increasing age, obesity, or who are immobile. More than 50% of VTEs result in patients undergoing hospitalization for surgery or acute illnesses, though the majority occur in patients post discharge. Pharmacists have an important role in promoting the utilization of VTE prophylaxis during hospitalization according to guidelines from leading organizations. In the past decade, direct oral anticoagulants (DOACs) have emerged with a role in VTE treatment and prophylaxis. Identifying patients who can benefit from anticoagulant management and VTE prophylaxis post discharge is essential to reduce clinical and economic burden as well as decrease risk of VTE recurrence and long-term complications. This activity will review the use of DOACs for extended-duration prophylaxis of VTEs and prevention of complications that patients at high risk of VTE may face post discharge.
Target audience: Health-system and oncology pharmacists
Type of activity: Application
Release date: September 21, 2021
Expiration date: September 21, 2022
Time to complete activity: 1.0 hour
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Identify patients who are at risk for developing venous thromboembolism (VTE)
- Examine the clinical burden of VTE in acutely ill medical patients and review the challenges patients face post discharge
- Determine the use of direct oral anticoagulants (DOACs) during admission and post discharge for extended VTE prophylaxis for high-risk, medically ill patients
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-21-338-H01-P. The activity is available for CE credit through September 21, 2022.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, view the webcast in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Disclosures
Sean P. Kane, PharmD, BCPS, has no relevant financial relationships with commercial interests to disclose.
Pharmacy Times Continuing Education™ Planning Staff – Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Michelle C. Carlson, PharmD; Dipti Desai, PharmD, CHCP; Kelly McCormick; Susan Pordon; Brianna Winters; and Chloe Taccetta have no relevant financial relationships with commercial interests to disclose.
An anonymous peer reviewer is used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this live CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms
